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Background: Protocols for the hormonal induction of ovulation and oviposition are essential tools for managing
threatened amphibians with assisted reproduction, but responses vary greatly between species and even broad
taxon groups. Consequently, it is necessary to assess effectiveness of such protocols in representative species when
new taxa become targets for induction. The threatened genus Mixophyes (family Myobatrachidae) has amongst the
highest proportion of endangered species of all the Australian amphibians. This study developed and optimised the
induction of oviposition in a non-threatened member of this taxon, the great barred frog (Mixophyes fasciolatus).
Methods: Gravid female M. fasciolatus were induced to oviposit on one or more occasions by administration of
human chorionic gonadotropin (hCG) with or without priming with pregnant mare serum gonadotropin (PMSG).
Treatments involved variations in hormone doses and combinations (administered via injection into the dorsal
lymph sacs), and timing of administration. Pituitary homogenates from an unrelated bufonid species (Rhinella
marina) were also examined with hCG.
Results: When injected alone, hCG (900 to 1400 IU) induced oviposition. However, priming with two time
dependent doses of PMSG (50 IU, 25 IU) increased responses, with lower doses of hCG (200 IU). Priming increased
response rates in females from around 30% (hCG alone) to more than 50% (p = 0.035), and up to 67%. Increasing
the interval between the first PMSG dose and first hCG dose from 3 to 6 days also produced significant
improvement (p<0.001). Heterologous pituitary extracts administered with hCG were no more effective than hCG
alone (p = 0.628).
Conclusions: This study found that M. fasciolatus is amongst the few amphibian species (including Xenopus
(Silurana) and some bufonids) that respond well to the induction of ovulation utilising mammalian gonadotropins
(hCG). The optimal protocol for M. fasciolatus involved two priming doses of PMSG (50 IU and 25 IU) administered
at 6 and 4 days respectively, prior to two doses of hCG (100 IU), 24 hours apart. This study is also the first to
demonstrate in an amphibian species that responds to mammalian gonadotropins that an increase in the ovulation
rate occurs after priming with a gonadotropin (PMSG) with FSH activity.
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Pituitary extracts have been widely used for many decades
as an effective and practical tool for obtaining viable
oocytes from gravid amphibians [1-6] since the first bioas-
says demonstrated the effects of pituitary extracts on am-
phibian ovulation. Pituitary extracts from the same
(homologous) species are the most effective at inducing
ovulation [2]. Homologous pituitaries are presumably the
most suitable and potent source of LH activity [2] for the
induction of ovulation because of sequence variation in
the active β unit of the gonadotropins [7] that impacts on
hormone-receptor specificity, an effect that is likely to in-
crease with phylogenetic distance. Heterologous pituitary
extracts from different amphibian species are a “second
best” source of LH activity [5] but still (with exceptions
such as Xenopus, Table 1) much more effective than
phylogenetically distant mammalian gonadotropins [2,8].
However, disadvantages of using heterologous or homolo-
gous pituitary extracts as a routine tool for inducingTable 1 Published protocols for the induction of oviposition i















X. laevis 50 IU, Day −14 to −5
(early ovulation if primi
after day −5; priming
effective up to 1 month
X. laevis 50-200 IU, Day 1 (−8 hr
X. laevis 40 IU, Day −4 to −3
X. laevis 50 IU, Day?
X. laevis 50 IU, Day −5 to −3
X. laevis 50 IU, Day −1725 IU, Day −14
X. laevis 100 IU, Day −1
X. tropicalis 20 IU, Day −2
X. tropicalis 15 IU, Day −4 to −3
Protocols for the induction of oviposition of Xenopus (X. laevis and X. (Silurana) trop
with FSH or LH activity. * Day of administration of priming dose of PMSG or hCG ex
values). ** Day of administration of “ovulatory” hCG dose expressed as Day 1 to fac
as either reconstituted or synthetic hCG (dose in IU) or as direct injection of pregna
hours after the main “ovulatory” dose of hCG on Day 1). Species names are from orovulation and oviposition in gravid females include indi-
vidual, gender and seasonal variability in FSH and LH ac-
tivity [6], availability of a source of pituitaries, and the cost
and inconvenience of the collection process. In the case of
endangered species, the potential for transfer of pathogens
in raw extracts [9] as well as the inappropriateness of
using rare or endangered animals to obtain pituitary
extracts argues for alternative induction protocols.
One great advantage of working with Xenopus spp
(X. laevis and X. (Silurana) tropicalis) in reproductive
and developmental biology studies involving amphibians
has been the ease with which ovulation of fertile eggs can
be induced with mammalian gonadotropic hormones, espe-
cially hCG as a source of LH activity [8] (Table 1). Xenopus
gained widespread attention in the 1930s [10] providing the
first effective, large scale pregnancy test for women because
of the reliability of its ovulatory response to hCG adminis-
tration (an application that persisted for many years). This
turned out to be an aspect of Xenopus biology shared withn Xenopus
“Ovulatory” hCG (dose or
source) on Day 1**
Oviposition*** References
Human pregnant urine Time not stated [2,10]
90 IU Time not stated [11]
100-200 IU (< 100 g bwt) + 6–12 hrs [12]
200–600 IU (> 100 g bwt)
300 IU Time not stated [13]
500 IU + 8–10 hrs [14]
500 IU Time not stated [15]
500-700 IU Day 1 [16]
750 IU + 8–12 hrs [17]
900 IU + 8–10 hrs [18]
1000 IU + 10 hrs [19]
1000 IU + 18 hrs [20]
ng
)
500-800 IU + 9–14 hrs [21]
s) 300-500 IU; Day 1 (0 hrs) + 8 hrs [22]
250-500 IU + 6–8 hrs [23]
700 IU Time not stated [24]
500 IU + 12–14 hrs [25]
500 IU (hCG inducible over
14 days from second PMSG)
+ 16–18 hrs [26]
500 IU Day 2, avg 68% [27]
100 IU Natural pairing [28]
150 IU + 4 hrs [29]
icalis) utilising hCG with, or without, priming with mammalian gonadotropins
pressed as days before the main “ovulatory” hCG dose (expressed as negative
ilitate comparison between studies listed in Tables 1 and 2; hCG administered
nt human urine (dose unknown) *** Time or day of oviposition (generally,
iginal papers, however, Xenopus tropicalis is now known as Silurana tropicalis.
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to mammalian gonadotropins in most species (Table 2)
and the desire to move away from pituitary extracts for
reasons outlined above has led to the development of
protocols based on other parts of the hypothalamic-
pituitary-gonadal axis. These include gonadotropic releas-
ing hormones (GnRH) to stimulate release of endogenous
gonadotropins [30-32], progesterone to directly induce oo-
cyte maturation and germinal vesicle breakdown [33,34],
and dopamine antagonists [35,36], as well as various
combinations of these with or without gonadotropins (for
recent reviews and discussions see [9,36,37]). Nevertheless,
as a first step to inducing ovulation in a novel target
species, it is reasonable to test the use of synthetic mam-
malian gonadotropins, to determine whether these are an
effective and inexpensive means of obtaining viable eggs,
as is the case in Xenopus.
Global declines since the 1960s have resulted in amphi-
bians experiencing the highest rate of decline and extinc-
tion of any vertebrate class over that period [44-46]. This
loss of amphibian biodiversity is primarily a function of a
global pandemic of chytridiomycosis. Amongst Austra-
lian frogs, the genus Mixophyes (commonly known as the
Barred Frogs) is amongst the most threatened genera.
Currently, >40% (3 out of 7) of extant Mixophyes species
are listed as vulnerable or endangered under Australian
federal and state legislation, as well as the IUCN Red List.
In the state of New South Wales, this figure is as high as
75% (3 out of 4) species of Mixophyes listed as endan-
gered or vulnerable. Consequently, protocols for assisted
reproduction, such as hormonal induction of ovulation
have the potential to contribute to management and con-
servation of species across the genus. Currently, there is
no data available for induced ovulation in gravid females
of Mixophyes species. Adding to this, the group (Family:
Myobatrachidae) is phylogenetically distant from many
other amphibian taxa, and may consequently be quite
different in its response to protocols that work well for
other amphibian taxa, including its response to the injec-
tion of pituitary homogenates from unrelated species.
Collectively the myobatrachids constitute about 50% of
Australian amphibian species; 22% (n = 23) are consid-
ered vulnerable or endangered with 3 (2.8%) considered
extinct; and they also constitute 48% of all threatened
Australian frogs [47].
This paper reports the outcome of analyses of data on
multiple ovulation and oviposition induction protocols
employed on Mixophyes fasciolatus (the great barred
frog). This species is the only non-threatened species of
the Mixophyes in New South Wales and one of the few
non-threatened species in Australia, and as such is an ap-
propriate model for establishing protocols for assisted re-
productive techniques (ART) for this genus. The data set
does not contain all feasible protocols for the inductionof ovulation (e.g. no data is available for effects of GnRHs
or dopamine antagonists), but has focussed on the use of
amphibian pituitary homogenates and mammalian FSH
and LH preparations.
The results have implications for optimising oocyte
collection in the other threatened Mixophyes species
and, more broadly, other Australian ground (myobatra-
chid and limnodynastid) frogs. The results also demon-
strate that, in species that respond to hCG, PMSG
priming is effective in increasing the rate of ovulation
(an assumption in some published protocols, not previ-
ously substantiated with data).Methods
Research described in this manuscript was undertaken
following approval by University of Newcastle Animal
Care and Ethics Committee which adheres to the NSW
Animal Research Act, NSW Animal Research Regula-
tion, and the Australian Code of Practice for the Care
and Use of Animals for Scientific Purposes (706 06 08 to
706 06 10), and M. fasciolatus were collected under per-
mit from the NSW National Parks and Wildlife Service.Sources and holding of animals
Adult female Mixophyes fasciolatus (great barred frogs)
were collected from the mid to north coast regions of New
South Wales, Australia (32o59’36.95”S; 151o26’44.23”E to
28o33’08.51”S; 153o18”31.72”E) during the spring to au-
tumn periods (September to April) and held in groups of
10–12 in large plastic containers (approximately 1 m × 2 m
× 1 m), with refuge sites provided as deep pine bark, leaf
litter, wood and eucalypt bark. Access to water and food
(brown crickets, Acheta domestica) was provided ad libi-
tum, and environmental conditions (temperature and day
length) were partially regulated by air-conditioning and
fluorescent lighting in a facility that received partial light-
ing through external glass windows. Ambient tempera-
tures varied between 16 and 28°C; light: dark cycle was
approximately 10 L: 14 D.
Individual females were identified by implanted Passive
Integrated Transponder (PIT) tags (GuangZhou Hon-
gTeng Barcode Technology Co. Ltd; Guangzhou). Females
were assigned randomly to treatments (oviposition induc-
tion protocols), and females were used between the
months of January and April over a period of two years.
Induction protocols are described below. A proportion of
females were subjected to induction attempts on more
than one occasion, but were rested for at least 2 months
between inductions (but generally longer than this, and up
to 1 year). No prior information was available on either
the seasonality of oogenesis, or the rate at which succes-
sive generations of mature oocytes are recruited to follicles
in this species.
Table 2 Results of attempts to induce oviposition in amphibians other than Xenopus with hCG
Species Priming or co-administered agent hCG [dose or source]* Oviposition** References
Bufo americanus Human pregnant urine None [2]
B. americanus No priming 100 IU, Day 1 None [38]
No priming 400-1000 IU, Day 1 about 60%, Day 2
Priming Day −2 [LH 50 ug, or LHRH 50 ug,
or eCG 50 IU, or hCG 50 IU]
500 IU, Day 1 ≤ 60%, Day 2
B. arenarum Human pregnant urine None [2]
B. baxteri 4.0 ug LHRHa, Day 1 [no priming] 500 IU, Day 1 None [35]
0.8 ug LHRHa, Day −4 100 IU, Day −4 70%, Day 1-2
4.0 ug LHRHa, Day 1 500 IU, Day 1
[total = 600 IU]
4.0 ug LHRHa, Day −6 500 IU, Day −6 80%, Day 1-2
0.8 ug LHRHa, Day −4 100 IU, Day −4
4.0 ug LHRHa, Day 1 500 IU, Day 1
[total = 1100 IU]
B. calamita Human pregnant urine None [2]
B. fowleri Human pregnant urine + [2]
B. fowleri 60 ug LHRHa, 5 mg progesterone,
0.25 mg pimozide, Day 1
500 IU, Day 1 85%, Day 1-2 [39]
4 ug LHRHa, Day −1 500 IU, Day −1 29%, Day 1-2
4 ug LHRHa, Day 1 500 IU, Day 1
[total = 1000 IU]
B. vulgaris Human pregnant urine None [2]
Eleutherodactylus coqui 25-140 IU, Day 1 None [40]
165-200 IU, Day 1 Day 2, weak response
(2/6 females)
Hyla aurea Pregnant mare serum - + [2]
Litoria aurea 5 ug LHRHa, Day −4.5 300 IU, Day 1 Weak; 1% of normal egg
release (2/5 females)
[41]
5 ug LHRHa, Day −1.5
10 ug LHRHa, Day −0.5
20 ug LHRHa, Day 1
Litoria moorei No benefit of including
progesterone
100-200 IU, Day −2 Weak; few eggs
in 1/14 females
[41]
500–750 IU, Day 1
Litoria raniformis 10 ug LHRHa, Day −4 500 IU, Day −4 None [42]
10 ug LHRHa, Day −2 500 IU, Day −2
10 ug LHRHa, Day 1 500 IU, Day 1
Rana catesbeiana Human pregnant urine + [2]
R. catesbeiana Pregnant mare serum - + [2]
R. clamitans Human pregnant urine None [2]
R. temporaria Human pregnant urine None [2]
R. esculenta Human pregnant urine None [2]
R. pipiens Human pregnant urine None [2]
R. pipiens Pregnant mare serum - None [2]
R. sevosa 3-4 ug LHRH, Day −3 100 IU, Day −3 + [37]
15–20 ug LHRH, Day 1 500 IU, Day 1
R. vulgaris Human pregnant urine None [2]
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Table 2 Results of attempts to induce oviposition in amphibians other than Xenopus with hCG (Continued)
Urodeles
Ambystoma tigrinum Human pregnant urine + [2]
Triturus pyrrogaster Human pregnant urine + [2]
T. torosus; Pregnant mare serum - None [2]
T. similans;
T. rivularis
T. viridescens Human pregnant urine + [2]
Results of attempts to induce oviposition utilising hCG administration in amphibian species other than Xenopus with, or without, priming with hCG or other
agents. * Day of final hCG injection expressed as Day 1, with administration of compounds on days prior to Day 1 expressed as negative values (to facilitate
comparison between studies listed in Tables 1 and 2); hCG administered as either reconstituted or synthetic hCG (dose in IU) or as direct injection of pregnant
human urine (dose unknown). ** Oviposition: “+”=oviposition recorded; “None”=no oviposition recorded. Data from [2] for PMSG only inductions (no hCG) for
some Rana species also shown. Species names are from original papers, however, some have since been renamed e.g. Rana pipiens now Lithobates pipiens by
some [43].
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Gravid, adult females were subjected to a number of in-
duction protocols, as indicated in Table 3. These were:
1. Controls given sham 250 μl saline injections
(Simplified Amphibian Ringer (SAR); [6]) once per
day for four days.
2. Varying cumulative doses of human chorionic
gonadotropin (hCG) (Chorulon, Intervet (300 IU/ml);
these were administered in the manufacturer’s
diluent over up to three days (mostly over two days)
in up to 4 aliquots to deliver the total doses indicated
in Table 3.Table 3 Oviposition by female M. fasciolatus after various mam
Treatment groups Day, time & number of females ovipositi
Day 1 2 3
Light/dark (24 hr)** D L L D D L L D D L






(3) hCG and pituitary glands
hCG 1200–1500+ 6 pituitaries 1 1
(4) PMSG and hCG (200 IU***)
50 PMSG; -3 days 1
75 PMSG;-4, -2 days**** 4
75 PMSG;-5, -3 days**** 6 6
75 PMSG;-6, -4 days**** 1 1 1
All PMSG and hCG (200 IU)
Oviposition by female M. fasciolatus after either (1) sham injections with saline (2) inje
human gonadotropin and 6 amphibian pituitary glands (B. marinus) (4) injection with
before administration of first of two doses of human chorionic gonadotropin. * Numb
12 hr D; each L or D represents 6 hrs ***hCG= 100 IU administered on each of days 1
dose = 25 IU administered on the indicated number of days before the first dose of hC3. hCG in combination with pituitary gland extracts
from adult male cane toads (Rhinella marina); each
female received pituitary extract injections on two
consecutive days, each containing extracts from 3
pituitary glands in 250 μl of SAR, and total hCG
injections (300 IU/ml in manufacturer’s diluent) over
up to 3 days as indicated in Table 3.
4. hCG preceded with priming injections of pregnant
mare serum gonadotropin Pregnant mare serum
gonadotropin (PMSG) (Folligon, Intervet, 200 IU/ml
in the manufacturer’s diluent) was administered
between 2 and 6 days prior to the first hCG
injection; 200 IU hCG was administered as twomalian gonadotropin treatments
ng Oviposition (%)*
4 5 6
L D D L L D D L L D D
0/6 (0%)
6/20 (30%)





1 6 1 1 21/41 (51%)
1 1 1 6/9 (67%)
32/68 (47%)
ctions with human chorionic gonadotropin (hCG) only (3) injections with
pregnant mare serum gonadotropin (PMSG) indicated number of days
er ovipositing/Number treated (% ovipositing) ** Light/Dark cycle = 12 hr L:
and 2. **** Where PMSG total dose = 75 IU: first dose = 50 IU; second
G.
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and 2 (Table 3), with the exception of a small
number of females where the hCG injections were
separated by 48 hours.
During the experimental period, females were main-
tained in individual vivaria on a 12 D: 12 L photoperiod
at room temperature. Compounds were administered by
injection into the dorsal lymph sacs via either a 23 or
26 G hypodermic needle.
Multiple inductions
About 50% of the females were used in induction proto-
cols on more than one occasion. Females used in more
than one induction were rested for at least 2 months be-
tween induction attempts (but generally for longer),
whether or not oviposition was observed in any preced-
ing induction attempt. Females used in more than one
induction attempt were randomly assigned to induction
protocols on the second or third induction i.e. there was
no systematic sequence, combination or set of induction
protocols used where females were induced more than
once. Thus, the data in Table 4 represents responses to
multiple induction attempts employing various combina-
tions of protocols (without systematic assignment).
Measures of response
Voluntary oviposition by females was used as the meas-
ure of response to induction protocols. Responses were
recorded as occurring or not occurring. After injections,
females were held in individual plastic vivaria for several
days to assess their responses. Oviposition was recorded
as oocytes deposited on the floor of vivaria; a small
amount of isotonic saline being added to the vivaria
around the time of oviposition to prevent desiccation of
oocytes. Prior to oviposition, females were hydrated by
small amounts of water added to the vivaria. Oocytes
were not collected by manual stimulation. Most oviposi-
tions involved the release of large numbers of oocytes
(ranging from several hundred up to approximately
1000). A small number of ovipositions were associatedTable 4 Effect of diurnal cycle on timing of oviposition by
M. fasciolatus











0 – 12 hours* 9 2 30 41
12 – 24 hours** 1 0 2 3
Effect of diurnal cycle on timing of oviposition by M. fasciolatus. Data from
Table 3. No significant effect of treatment group on timing of oviposition
(p = 0.625); significant effect of stage of diurnal cycle on oviposition timing
(p<0.0001). * 0–12 hours = 0:00–6:00 hr dark, 6:00–12:00 hr light; **12-
24 hours = 12:00–18:00 hr light, 18:00–24:00 hr dark.with the release of fewer oocytes. The viability of several
batches of oocytes was confirmed by in vitro fertilisation
with sperm of male M. fasciolatus, with observations to
the neurula stage. It is assumed in this study that ovipos-
ition indicates the occurrence of ovulation immediately
prior to oviposition (as a result of the hormonal induc-
tion protocols), although no experiments were done to
directly demonstrate this.Statistics
Data on the frequency of oviposition between treatments
and treatment groups were analysed using non-
parametric statistics. To avoid problems with expected
frequencies less than 5, all frequency statistics were ana-
lysed using Fisher Exact Probability Tests (http://vassar-
stats.net/; last accessed July 8, 2012), and employing the
Freeman-Halton extension for contingency tables greater
than 2 × 2. Data for the proportion of PMSG primed
females ovipositing were plotted against time since first
PMSG injection and the significance of the regression
and correlation coefficients determined by least squares
regression analysis.Results
A comparison of protocols
Controls (Group 1, Table 3) No ovipositions were
recorded in females subjected to saline only injections.
This supports the conclusion that where ovipositions
were recorded in hormonal treatment groups, these were
a result of those treatments (p = 0.056, Table 5).
hCG alone (Group 2, Table 3) Administration of hCG
alone was shown to induce oviposition with doses total-
ling 900 to 1400 IU per female (Table 3). The overall
oviposition rate in hCG only females was 27%. There
was no evidence (p = 0.512) that increasing the total dose
above 900 IU increased the rate of oviposition when
hCG was the only treatment. hCG doses below 900 IU
without the administration of other compounds were
not tested in this study. Ovipositions with hCG alone
were recorded up to 4 days after the initial injections,Table 5 Matrix of Fisher exact test p values (one tailed)
from data in Table 3
All
treatments





Saline Control 0.056 (6,112) 0.182 (6,37) 0.269 (6, 7) 0.028 (6,68)




- - 0.300 (7,68)
Matrix of Fisher exact test p values (one tailed) from data in Table 3 for
comparisons between treatment groups of proportion of female M. fasciolatus
ovipositing. Sample sizes of tested groups shown in parentheses.
Table 6 Proportions of female M. fasciolatus ovipositing
after repeated induction attempts
Number of times induction attempted 1 2 3
Number of females 29 20 6
Number of females ovipositing at least once 16 13 6
% females ovipositing at least once 55%a 65%a,b 100%b
Number of females ovipositing twice 5 (25%) 0
Capacity of female M. fasciolatus held under captive conditions to oviposit
after induction attempts on more than one occasion. The data are pooled
from all induction attempts across all protocols. Repeated attempts at
induction of oviposition were separated by resting periods of at least
2 months. Percentages with different superscripts on the same row are
significantly (p<0.05) different.
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second day.
hCG and pituitary glands (Group 3, Table 3) The
overall oviposition rate in females treated with hCG and
pituitary gland extracts was 29% (Table 3), which was
not significantly different from the proportion of females
ovipositing following hCG only treatments (p = 0.628,
Table 5). No females were administered pituitary gland
extracts without hCG in this study. All ovipositions oc-
curred by the end of the night of the second day after
the first injections.
hCG following PMSG priming (Group 4, Table 3)
Some ovipositions with PMSG priming occurred earlier
than any ovipositions with hCG alone. Taken together,
the rate of oviposition in females subjected to PMSG
priming prior to hCG injections (47%, Table 3) was sig-
nificantly higher than in females subjected to hCG only
(27%, Table 3; p = 0.035, Table 5). Ovipositions were
recorded up to 6 days after the initial hCG injection, but
most occurred from the morning of the third day
through to the morning of the fourth day after the first
hCG injection.
There was a significant increase (p<0.001) in the rate
of oviposition as a function of the time between the first
PMSG injection and the first hCG injection, based on
the regression of the percentage oviposition rate against
the interval between first PMSG and first hCG (Figure 1)
i.e. the oviposition rate was higher when PMSG priming
began 5 to 6 days before first hCG than when it began
closer to the first day of hCG administration.
Repeated (multiple) inductions
Data from Table 6 shows the response of females to in-
duction attempts performed on more than one occasion.
5/20 (25%) females in which inductions were attempted
twice, ovulated twice. This indicates the capacity of
females to go through multiple ovarian cycles andFigure 1 Regression of mean% female M. fasciolatus
ovipositing against time from first PMG injection to first hCG
injection. Data from Treatment Group “PMSG and hCG” in Table 3
(R2 = 0.9994; p<0.001).repeated ovulation and oviposition events in captivity.
The total proportion of females subjected to induction
protocols that oviposited at least once, increased with
multiple induction attempts to 100% by the third at-
tempt (Table 6); this trend of increasing proportion of
females ovipositing at least once with repeated induction
attempts indicates most, if not all, females held were in
reproductive condition at some point, if not continu-
ously over the duration of the study.
Timing of oviposition
Oviposition occurred most frequently in the period in-
cluding the second half of the dark period (0:00–
6:00 hrs, Table 3) and the first half of the light period
(6:00–12:00 hours, Table 3) of the daily photoperiod
cycle, suggesting a behavioural orientation towards noc-
turnal oviposition (p<0.0001; Table 4) that may continue
early into the light period.
Discussion
This study adds M. fasciolatus to the small group of am-
phibian species (including Xenopus laevis, Silurana tro-
picalis, and some bufonids) that will ovulate and
oviposit in response to protocols based only on mamma-
lian gonadotropins. The range of hCG doses associated
with successful oviposition in M. fasciolatus are similar
to the range of doses reported in various Xenopus/Silur-
ana protocols (this study up to 1400 IU, but optimised
to 200 IU with PMSG priming; compared to Xenopus/
Silurana 90 to 1000 IU without FSH/PMSG priming,
250 to 500 IU with priming; Table 1). The absolute dose
for M. fasciolatus (not adjusted for body weight differ-
ences) is similar or less than that required to induce B.
americanus and B. fowleri (Table 2). It is assumed that
oviposition in this study also indicates ovulation occur-
ring as a result of the induction process (as would be the
case with most studies investigating the induction of ovi-
position in amphibians), although this was not tested
directly; there are no published data on anurans known
to the authors where ovulation and oviposition have
been shown not to be linked, sequential events.
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with a gonadotropin with FSH activity. It was demon-
strated in this study that the rate of ovulation can be
increased from around 30% to more than 50% by prim-
ing females with PMSG. Interestingly, the benefits of
priming were increased by extending the interval be-
tween the first PMSG priming dose and the first hCG
dose. Based on the data from this study, the optimal
protocol for inducing oviposition in M. fasciolatus
involves injection of two priming doses of PMSG (50 IU
and 25 IU) administered 6 and 4 days, respectively, prior
to the injection of two ovulatory doses of 100 IU hCG,
administered 24 hours apart.
Published induction protocols utilising hCG (Tables 1,2)
identify Xenopus and Silurana species from the family
Pipidae as those that respond most strongly to hCG,
administered alone or in combination with a mammalian
gonadotropin with FSH priming activity, or with other
components of the hypothalamo-pituitary-gonadal path-
way (Table 1). The data in Table 1 indicates a wide range
of hCG concentrations (from 90 IU to 1000 IU in X. laevis
as single hCG doses, a range of an order of magnitude)
have been used to induce Xenopus laevis and Silurana tro-
picalis. An apparent higher sensitivity to hCG by S. tropi-
calis may reflect its smaller body size [48]. Various
protocols in Table 1 have also reported benefits of priming
the ovaries with either lower, anovulatory doses of hCG,
or with PMSG to prime for maturation. Nevertheless,
there do not appear to be reports of data on the gener-
ation of dose response curves for induction (hence the
wide variation in protocols), even in Xenopus, which
might indicate optimal doses that achieve maximum egg
generation with the minimum hCG dose, nor which indi-
cate the quantitative impacts of priming with hCG or
PMSG. Most published Xenopus/Silurana protocols do
not incorporate FSH priming (although a number of pro-
tocols have an hCG “priming” dose - see Table 1).
Although some Xenopus/Silurana protocols report
priming doses of PMSG (Table 1), the authors of this
study are unaware of a direct comparison in any study
of protocols with and without priming that would prove
a benefit of priming with FSH. This study thus provides
the only published data that demonstrates in any am-
phibian species an increase in ovulation rate as a result
of such priming, and that the maturational effect of
priming increases with time since administration. FSH is
common in mammalian protocols, recognising the role
that FSH plays in recruiting follicles and priming the
maturing follicle for ovulation by cumulus expansion
during the LH induced resumption of meiosis and ger-
minal vesicle breakdown [49,50]. LH but not FSH [51]
causes a rise in progesterone in Xenopus follicles, indi-
cating a separate, non-progesterone effect of FSH on fol-
licle maturation.Many anuran taxa, including various species of ranids,
hylids and some bufonids (listed in Table 1) do not re-
spond well (do not ovulate or ovulate at a very low rate)
to induction with mammalian homologues of the amphib-
ian gonadotropic hormones (a fact recognised many years
ago: see [2,6]). The data in Table 2 shows that, in particu-
lar, ranids as a group are the least responsive to mamma-
lian homologues of any higher amphibian taxon that has
been studied in detail (resulting in the continued use of pi-
tuitary extracts for induction in this group, see below);
bufonids are highly variable in their responses – many
species have not been recorded as responding to mamma-
lian homologues, others respond in conjunction with
other effectors of the hypothalamic-pituitary-gonadal axis
such as LHRH and progesterone, while at least two spe-
cies (B. americanus and B. fowleri) respond reasonably
well to hCG only inductions. Some less studied groups
such as the Australasian hylids and the eleutherodactylids
may or may not be poor responders, with results obtained
on a small sample of species. In contrast, a number of uro-
deles appear to respond well to hCG.
Nevertheless, effective hCG doses for Xenopus and
Mixophyes fasciolatus (allowing for differences in body
weight) are high compared to doses reported to be ef-
fective in inducing ovulation in mammals (mouse 5 IU
[52,53], dog 500 IU [54], rhesus monkey 4000 IU [55],
cheetah 100–250 IU [56], cows 1500 to 2500 IU [57,58],
mares 2,000 – 3,300 IU [59,60]; for example, the opti-
mised dose of hCG used to induce oviposition in M. fas-
ciolatus in this study (200 IU with PMSG priming)
would have been sufficient to induce ovulation in 2
cheetahs [56]. This large differential in effective dose be-
tween mammals and responsive amphibians is also
noted by Kouba and Vance [37] who observed that the
ovulatory dose of hCG for Xenopus is 2000 times for
that for the tiger. hCG is a convenient source of mam-
malian LH activity, but other mammalian sources are
not necessarily more potent [8].
Given the challenges of inducing ovulation with mam-
malian homologues, pituitary extracts have continued to
be used in many species to induce ovulation including
bufonids [61], ranids [3,62,63] and at least one other
myobatrachid [4]. No data were generated in this study on
the capacity of amphibian pituitary gland extracts alone to
induce ovulation and oviposition in M. fasciolatus, and
there was no evidence (although the approach was not
exhaustively investigated) of pituitary extracts potentiating
the effects of the mammalian gonadotropins. The source of
amphibian pituitary extracts in this study was Rhinella
marina, which is not closely related to the Mixophyes [64].
The effect of homologous pituitary extracts remains un-
tested in this species.
The results of this study do not preclude further work
on this or other myobatrachid species to improve the
Clulow et al. Reproductive Biology and Endocrinology 2012, 10:60 Page 9 of 10
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approaches. The use of gonadotropin releasing hormone
analogues to induce ovulation has been reported in
other myobatrachid species, Pseudophryne guentheri [65]
and P. corroboree [66]. Investigations focussing on com-
bining gonadotropin releasing hormones and dopamine
antagonists [39] might also improve success rates and
the control of timing of ovulation and oviposition in
M. fasciolatus and other Mixophyes species, as might
various combinations of hCG or other gonadotropins
with progesterone [35,37].
Mixophyes frogs are one of the most threatened Austra-
lian myobatrachid genera (with only Taudactylus contain-
ing a higher proportion of threatened species). There is
one instance of captive breeding reported in a Mixophyes
species (M. fasciolatus at Melbourne Zoo; [67]). In the fu-
ture, captive breeding approaches in this and other Mixo-
phyes species may be augmented by assisted reproduction
using techniques including induced ovulation for in vitro
fertilisation that allow specific individuals to be paired for
optimal genetic management, and improve efficiency and
reduce costs in resource limited captive programs, and
play a role in breeding programs selecting for disease re-
sistance, such as against chytridiomycosis.
Conclusions
This study found that M. fasciolatus is amongst the few
amphibian species (including Xenopus (Silurana) and
some bufonids) that respond well to the induction of
ovulation utilising mammalian gonadotropins (hCG).
The optimal protocol for M. fasciolatus involved two
priming doses of PMSG (50 IU and 25 IU) administered
at 6 and 4 days respectively, prior to two doses of hCG
(100 IU), 24 hours apart. This study is also the first to
demonstrate in an amphibian species that responds to
mammalian gonadotropins that an increase in the ovula-
tion rate occurs after priming with a gonadotropin
(PMSG) with FSH activity.
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